“How Do I Learn More About this?”: Utilization and Trust of Psychedelic Information Sources Among People Naturalistically Using Psychedelics

References

• Aday, J. S., E. K. Bloesch, and C. C. Davoli. 2020. 2019: A year of expansion in psychedelic research, industry, and deregulation. Drug Science, Policy and Law 6 (January):2050324520974484. SAGE Publications. doi:10.1177/2050324520974484.
   Google Scholar
• Alexandrescu, L. 2013. Mephedrone, assassin of youth: the rhetoric of fear in contemporary drug scares. Crime, Media, Culture: An International Journal 10 (1):23–37. doi:10.1177/1741659013511975.
   Web of Science ®Google Scholar
• Anderson, J. G. 2016. Consumers of E-Health. Social Science Computer Review 22 (2):242–48. doi:10.1177/0894439303262671.
   Google Scholar
• Andrews, T., and K. Wright. 2022. The frontiers of new psychedelic therapies: A survey of sociological themes and issues. Sociology Compass 16 (2):e12959. doi:10.1111/soc4.12959.
   Web of Science ®Google Scholar
• Barratt, M. J. 2011. Discussing illicit drugs in public internet forums: visibility, stigma, and pseudonymity, 159–68. New York: ACM. doi:10.1145/2103354.2103376.
   Google Scholar
• Blackman, S., R. Bradley, M. Fagg, and N. Hickmott. 2018. Towards “sensible” drug information: Critically exploring drug intersectionalities, “just say no,”. Normalisation and Harm Reduction Drugs: Education, Prevention and Policy 25 (4):320–28. Taylor & Francis. doi:10.1080/09687637.2017.1397100.
   Web of Science ®Google Scholar
• Blood, R. W., J. Williams, and K. McCallum. 2003. Representations oF public risk: illegal drugs in the Australian press. Media International Australia 108 SAGE Publications Ltd:1–10082–100. doi:10.1177/1329878X0310800110.
   Google Scholar
• Bright, S. J., A. Marsh, L. M. Smith, and B. Bishop. 2008. What can we say about substance use? dominant discourses and narratives emergent from Australian media. Addiction Research & Theory 16 (2):135–48. Taylor & Francis. doi:10.1080/16066350701794972.
   Web of Science ®Google Scholar
• Carhart-Harris, R. L., L. Roseman, E. Haijen, D. Erritzoe, R. Watts, I. Branchi, and M. Kaelen. 2018. Psychedelics and the essential importance of context. Journal of Psychopharmacology (Oxford, England) 32 (7):725–31. doi:10.1177/0269881118754710.
   PubMed Web of Science ®Google Scholar
• Dollar, B., and Cindy. 2022. Heads, seekers, psychonauts, and one-timers: Patterns in stories of psychedelic consumption. Journal of Drug Issues September SAGE Publications Inc:00220426221128191. doi:10.1177/00220426221128191.
   Google Scholar
• Duxbury, S. W. 2018. Information creation on online drug forums: How drug use becomes moral on the margins of science. Current Sociology 66 (3):431–48. doi:10.1177/0011392115596055.
   Web of Science ®Google Scholar
• Enghoff, O., and J. Aldridge. 2019. The value of unsolicited online data in drug policy research. International Journal of Drug Policy 73 (November):210–18. doi:10.1016/j.drugpo.2019.01.023.
   PubMedGoogle Scholar
• European Commission. 2014. Flash eurobarometer 401: Young people and drugs. Luxembourg: European Commission. http://ec.europa.eu/commfrontoffice/publicopinion/flash/fl_401_en.pdf.
   Google Scholar
• Falck, R. S., R. G. Carlson, J. Wang, and H. A. Siegal. 2004. Sources of information about MDMA (3,4-methylenedioxymethamphetamine): Perceived accuracy, importance, and implications for prevention among young adult users. Drug and Alcohol Dependence 74 (1):45–54. doi:10.1016/j.drugalcdep.2003.11.009.
   PubMed Web of Science ®Google Scholar
• Giffort, D. 2020. Who controls your cortex?: Moral panic and the politicization of psychedelic drugs. Acid Revival. 101–34. The Psychedelic Renaissance and the Quest for Medical Legitimacy. University of Minnesota Press. doi:10.5749/j.ctv13qfvv7.8.
   Google Scholar
• Hadar, A., J. David, N. Shalit, L. Roseman, R. Gross, B. Sessa, and S. Lev-Ran. 2022. The psychedelic renaissance in clinical research: A bibliometric analysis of three decades of human studies with psychedelics. Journal of Psychoactive Drugs, 55 (1):1–10. Taylor & Francis. doi:10.1080/02791072.2021.2022254.
   PubMed Web of Science ®Google Scholar
• Hartogsohn, I. 2017. Constructing drug effects: A history of set and setting. Drug Science, Policy and Law, 3 (January):2050324516683325. SAGE Publications. doi:10.1177/2050324516683325.
   Google Scholar
• Krebs, T. S., and P.Ø. Johansen. 2013. Over 30 million psychedelic users in the United States. F1000research 2:98. doi:10.12688/f1000research.2-98.v1.
   PubMedGoogle Scholar
• Kruger, D. J., N. G. Glynos, C. W. Fields, M. Herberholz, and K. F. Boehnke. 2022. An assessment of psychedelic knowledge among people using psychedelics naturalistically. Journal of Psychoactive Drugs. 1–5. Taylor & Francis. doi:10.1080/02791072.2022.2142709.
   Web of Science ®Google Scholar
• Kruger, J. S., D. J. Kruger, and R. Lorraine Collins. 2021. Knowledge and practice of harm reduction strategies among people who report frequent cannabis use. Health Promotion Practice 22 (1):24–30. doi:10.1177/1524839920923999.
   PubMed Web of Science ®Google Scholar
• Lindsay, S., K. Rea, N. J. Lachowsky, and E. Abella Roth. 2022. Magic mushroom use: a qualitative interview study of post-trip impacts and strategies for optimizing experiences. Journal of Psychoactive Drugs. 1–8. Taylor & Francis. doi:10.1080/02791072.2022.2054746.
   Web of Science ®Google Scholar
• Madelene, P., and O. M. Maynard. 2022. Are you tripping comfortably? Investigating the relationship between harm reduction and the psychedelic experience. Harm Reduction Journal 19 (1):81. doi:10.1186/s12954-022-00662-0.
   PubMed Web of Science ®Google Scholar
• Mann, B., and M. Bebinger. Purdue pharma, sacklers reach $6 billion deal with state attorneys general. NPR. March 3, 2022. sec. Health https://www.npr.org/2022/03/03/1084163626/purdue-sacklers-oxycontin-settlement.
   Google Scholar
• Månsson, J. 2016. The same old story? Continuity and change in Swedish print media constructions of cannabis. Nordic Studies on Alcohol and Drugs 33 SAGE Publications Ltd STM:3–286267–286. doi:10.1515/nsad-2016-0021.
   Web of Science ®Google Scholar
• Moore, D. 2008. Erasing pleasure from public discourse on illicit drugs: On the creation and reproduction of an absence. International Journal of Drug Policy 19 (5):353–58. doi:10.1016/j.drugpo.2007.07.004.
   PubMed Web of Science ®Google Scholar
• Noorani, T. 2020. Making psychedelics into medicines: The politics and paradoxes of medicalization. Journal of Psychedelic Studies, 4 (1):34–39. Akadémiai Kiadó. doi:10.1556/2054.2019.018.
   Google Scholar
• Park, E., and M. Kwon. 2018. Health-related internet use by children and adolescents: Systematic review. Journal of Medical Internet Research 20 (4):e7731. doi:10.2196/jmir.7731.
   Web of Science ®Google Scholar
• Peipert, T. Colorado voters consider legalizing psychedelic mushrooms. PBS NewsHour. November 8, 2022. sec. Politics https://www.pbs.org/newshour/politics/colorado-voters-consider-legalizing-psychedelic-mushrooms.
   Google Scholar
• Petersen, M. A., A. Smith, D. Brogaard Kristensen, and K. Hoeyer. 2022. Subject in the making: Technologies of the self and aspirations for a good life in contemporary denmark. Medical Anthropology 41 (4):431–45. Routledge. doi:10.1080/01459740.2022.2054716.
   PubMed Web of Science ®Google Scholar
• Psychedelic Alpha. 2022. Psychedelics legalization & decriminalization tracker. Psychedelic Alpha. https://psychedelicalpha.com/data/psychedelic-laws.
   Google Scholar
• Richert, L., E. Dyck, and A. Turner. 2021. Psychedelic wars: LSD as mental medicine in a battle for hearts and minds. The War on Drugs: A History. 186–212. New York University Press. doi:10.18574/nyu/9781479811397.003.0010.
   Google Scholar
• Sessa, B. 2012. The psychedelic renaissance: Reassessing the role of psychedelic drugs in 21st century psychiatry and society. United Kingdom: Muswell Hill Press.
   Google Scholar
• Shearer, E. 2022. More than eight-in-ten Americans get news from digital devices. Pew Research Center. Accessed December 2. https://www.pewresearch.org/fact-tank/2021/01/12/more-than-eight-in-ten-americans-get-news-from-digital-devices/.
   Google Scholar
• Tighe, B., M. Dunn, F. H. McKay, and T. Piatkowski. 2017. Information sought, information shared: Exploring performance and image enhancing drug user-facilitated harm reduction information in online forums. Harm Reduction Journal 14:1. doi:10.1186/s12954-017-0176-8.
   PubMed Web of Science ®Google Scholar
• Tvorun-Dunn, M. 2022. Acid liberalism: Silicon valley’s enlightened technocrats, and the legalization of psychedelics. International Journal of Drug Policy 110 (December):103890. doi:10.1016/j.drugpo.2022.103890.
   PubMedGoogle Scholar
• Walsh, C. 2011. Drugs, the internet and change. Journal of Psychoactive Drugs 43 (1):55–63. doi:10.1080/02791072.2011.566501.
   PubMed Web of Science ®Google Scholar
• Yockey, R. A., and K. King. 2021. Use of psilocybin (“mushrooms”) among US adults: 2015–2018. Journal of Psychedelic Studies, 5 (1):17–21. Akadémiai Kiadó. doi:10.1556/2054.2020.00159.
   Google Scholar
• Yockey, R. A., R. A. Vidourek, and A. K. Keith. 2020. Trends in LSD use among US adults: 2015–2018. Drug and Alcohol Dependence 212 (July):108071. doi:10.1016/j.drugalcdep.2020.108071.
   PubMedGoogle Scholar